The first half of 2024 has been remarkable growth and transformation for the European startup ecosystem. Marked by significant increases in funding and investment, this period has showcased Europe's dynamic entrepreneurial environment.

Surge in Deals and Funding

In the first six months of 2024, the European startup landscape saw a total of 1,936 deals, accompanied by a staggering $54.42 billion in funding. This represents a 102% increase in funding year-over-year, reflecting heightened investor confidence and robust market activity. Additionally, there were 480 exits during this period, further emphasizing the vibrancy of the ecosystem.

Major Venture Capital Rounds

The venture capital scene in H1 2024 was highlighted by several major funding rounds. Abound led the way with an impressive $1.02 billion Series B round, matched by Wayve's $1.02 billion Series C round. Following closely were Mistral AI with a $640 million Series B round, Monzo with a $435 million Series I round, and Picnic with a $384 million Series E round. These substantial investments underscore the growing appeal and potential of European startups.

Noteworthy Exits

On the exit front, H1 2024 witnessed blockbuster deals that reshaped the European startup landscape. Novo Nordisk's acquisition of Cardior for a staggering $1.1 billion and AstraZeneca's $1.05 billion purchase of Amolyt Pharma were standout transactions. Adding to the momentum, Bridgepoint's acquisition of Lumapps for $650 million underscored significant strategic shifts and consolidation within the industry.

The first half of 2024 has solidified Europe's position as a leading hub for innovation and investment. With record-breaking funding rounds and significant exits, the European startup ecosystem is poised for continued growth and development, setting a strong foundation for the remainder of the year.